BJPsych Open (Jul 2018)
Defining a mood stabiliser: novel framework for research and clinical practice
- Gin S. Malhi,
- Richard Porter,
- Lauren Irwin,
- Amber Hamilton,
- Grace Morris,
- Darryl Bassett,
- Bernhard T. Baune,
- Philip Boyce,
- Malcolm J. Hopwood,
- Roger Mulder,
- Gordon Parker,
- Zola Mannie,
- Tim Outhred,
- Pritha Das,
- Ajeet B. Singh
Affiliations
- Gin S. Malhi
- ORCiD
- Treatment Algorithm Group (TAG), Academic Department of Psychiatry, Northern Sydney Local Health District, Sydney Medical School Northern, University of Sydney, Australia and CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District, Australia
- Richard Porter
- Treatment Algorithm Group (TAG) and Department of Psychological Medicine, University of Otago – Christchurch, New Zealand
- Lauren Irwin
- ORCiD
- Treatment Algorithm Group (TAG), Academic Department of Psychiatry, Northern Sydney Local Health District, Sydney Medical School Northern, University of Sydney, Australia and CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District, Australia
- Amber Hamilton
- Treatment Algorithm Group (TAG), Academic Department of Psychiatry, Northern Sydney Local Health District, Sydney Medical School Northern, University of Sydney, Australia and CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District, Australia
- Grace Morris
- Treatment Algorithm Group (TAG), Academic Department of Psychiatry, Northern Sydney Local Health District, Sydney Medical School Northern, University of Sydney, Australia and CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District, Australia
- Darryl Bassett
- Treatment Algorithm Group (TAG) and University of Western Australian Medical School, Australia, Faculty of Health and Medical Science, University of Western Australia, Australia
- Bernhard T. Baune
- Treatment Algorithm Group (TAG) and Discipline of Psychiatry, University of Adelaide, Australia
- Philip Boyce
- Treatment Algorithm Group (TAG) and Discipline of Psychiatry, Sydney Medical School, Australia and Westmead Clinical School, University of Sydney, Australia
- Malcolm J. Hopwood
- Treatment Algorithm Group (TAG) and Department of Psychiatry, University of Melbourne, Australia
- Roger Mulder
- Treatment Algorithm Group (TAG) and Department of Psychological Medicine, University of Otago – Christchurch, New Zealand
- Gordon Parker
- Treatment Algorithm Group (TAG) and School of Psychiatry, University of New South Wales, Australia and Black Dog Institute, Australia
- Zola Mannie
- Treatment Algorithm Group (TAG), Academic Department of Psychiatry, Northern Sydney Local Health District, Sydney Medical School Northern, University of Sydney, Australia and CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District, Australia
- Tim Outhred
- Treatment Algorithm Group (TAG), Academic Department of Psychiatry, Northern Sydney Local Health District, Sydney Medical School Northern, University of Sydney, Australia and CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District, Australia
- Pritha Das
- Treatment Algorithm Group (TAG), Academic Department of Psychiatry, Northern Sydney Local Health District, Sydney Medical School Northern, University of Sydney, Australia and CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District, Australia
- Ajeet B. Singh
- Treatment Algorithm Group (TAG) and School of Medicine, IMPACT Strategic Research Centre, Deakin University, Barwon Health, Australia
- DOI
- https://doi.org/10.1192/bjo.2018.36
- Journal volume & issue
-
Vol. 4
pp. 278 – 281
Abstract
The term ‘mood stabiliser’ is ill-defined and lacks clinical utility. We propose a framework to evaluate medications and effectively communicate their mood stabilising properties – their acute and prophylactic efficacy across the domains of mania and depression. The standardised framework provides a common definition to facilitate research and clinical practice.
Keywords
